Answers are grounded in this paper and cite their sources.
These recommendations concern the use of aluminum hydroxide adsorbed cell-free anthrax vaccine (Anthrax Vaccine Adsorbed [AVA], BioPort Corporation, Lansing, MI) in the United States for protection against disease caused by Bacillus anthracis. In addition, information is included regarding the use of chemoprophylaxis against B. anthracis.
No takes yet. Share an insight, caveat, or question.
A 2001 study studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: